Can fatty liver and hepatitis b together harm kidneys? a study digs into the data
NCT ID NCT07730736
First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time
Summary
This study looks back at the medical records of 1,000 adults with both chronic hepatitis B and metabolic fatty liver disease. The goal is to understand how these conditions affect kidney function, especially in people on long-term antiviral therapy. Researchers will also examine whether different traditional Chinese medicine syndrome types are linked to different levels of liver scarring. No new treatments or tests are given—only existing data is analyzed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help identify early signs of kidney damage in patients with chronic hepatitis B and fatty liver disease, potentially guiding safer long-term antiviral treatment.
- What could go wrong
- This is an observational study that looks back at existing medical records, so it cannot prove cause and effect. The findings may not apply to all patients or lead to changes in treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Foshan Hospital of Traditional Chinese Medicine
Foshan, Guangdong, 528000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Can a new injection tame chronic hepatitis b?
- Double liver trouble: does having both hepatitis b and fatty liver speed up disease?
- A second punch against hepatitis b: interferon after RNA drugs may clear the virus
- Could common hepatitis b drugs damage kidneys? a study digs into the data
- Can a new shot help control hepatitis d in people with hepatitis b?